Back to Search Start Over

B cell tolerance and antibody production to the celiac disease autoantigen transglutaminase 2.

Authors :
du Pré MF
Blazevski J
Dewan AE
Stamnaes J
Kanduri C
Sandve GK
Johannesen MK
Lindstad CB
Hnida K
Fugger L
Melino G
Qiao SW
Sollid LM
Source :
The Journal of experimental medicine [J Exp Med] 2020 Feb 03; Vol. 217 (2).
Publication Year :
2020

Abstract

Autoantibodies to transglutaminase 2 (TG2) are hallmarks of celiac disease. To address B cell tolerance and autoantibody formation to TG2, we generated immunoglobulin knock-in (Ig KI) mice that express a prototypical celiac patient-derived anti-TG2 B cell receptor equally reactive to human and mouse TG2. We studied B cell development in the presence/absence of autoantigen by crossing the Ig KI mice to Tgm2-/- mice. Autoreactive B cells in Tgm2+/+ mice were indistinguishable from their naive counterparts in Tgm2-/- mice with no signs of clonal deletion, receptor editing, or B cell anergy. The autoreactive B cells appeared ignorant to their antigen, and they produced autoantibodies when provided T cell help. The findings lend credence to a model of celiac disease where gluten-reactive T cells provide help to autoreactive TG2-specific B cells by involvement of gluten-TG2 complexes, and they outline a general mechanism of autoimmunity with autoantibodies being produced by ignorant B cells on provision of T cell help.<br /> (© 2019 du Pré et al.)

Details

Language :
English
ISSN :
1540-9538
Volume :
217
Issue :
2
Database :
MEDLINE
Journal :
The Journal of experimental medicine
Publication Type :
Academic Journal
Accession number :
31727780
Full Text :
https://doi.org/10.1084/jem.20190860